SecBot SecBot
6-K ·Filed Nov 9, 2026
DA

DAVI

DAVION HEALTHCARE PLC
NEUTRAL
Impact 2/10
Horizonmonths Processed12d 23h ago SEC0001683168-26-008401
Notable filing: 6-K
Actionable Insight • Neutral

Monitor for any binding lender commitments or definitive acquisition agreements. The $100M target is aspirational and uncommitted; execution risk is high given the company's $35M market cap.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$1.75
T+0 close · Nov 9, 2026 · via day close
Latest settled
−41.71%
T+5 · $1.02
Vs SPY
−40.02%
α at T+5
Next horizon
T+20
in 16d
  1. T+0 · Nov 9 $1.75entry
  2. T+1 · 12d ago −9.71%α −9.35% · $1.58
  3. T+5 · 6d ago −41.71%α −40.02% · $1.02
  4. T+9 · todayOpen
  5. T+20 · in 16d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Davion Healthcare appointed Vienna Capital Partners as financial advisor to support a proposed US$100 million acquisition financing strategy for 2027. The filing is a strategic update with no committed financing, no binding lender commitments, and no financial results reported.

Key Facts

  • Davion entered a non-exclusive financial advisory agreement with Vienna Capital Partners LLC.
  • Initial aggregate financing objective of US$100 million for acquisitions in 2027.
  • No binding lender commitments have been secured; the $100M target is indicative only.
  • Company intends to use senior secured, non-convertible debt to minimize equity dilution.
  • Davion has a market cap of $35M; the $100M target is nearly 3x its market cap.
  • The filing follows a previously announced proposed $13.5M acquisition of Healthcare Stat Homecare Inc.

Financial Impact

Indicative $100M financing target; no committed funds. No financial results reported.

Risk Factors

  • No committed financing; the $100M target may not materialize.
  • Company has a $35M market cap; a $100M debt program would be highly leveraged.
  • Acquisition strategy depends on identifying and closing suitable targets; no assurance of completion.
  • Forward-looking statements subject to numerous risks including financing availability and integration.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001683168-26-008401
Document: davion_6k.htm0001683168-26-008401
Document: 0001683168-26-008401-index-headers.html0001683168-26-008401
Document: 0001683168-26-008401-index.html0001683168-26-008401
Document: 0001683168-26-008401.txt0001683168-26-008401
Earnings Context (Synthetic; results releases only)0001683168-26-008401

US Market Status

Market Closed · Opens Mon (25h 57m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026